Compounds > ciprofloxacin

ciprofloxacin and ro-23-9424

ciprofloxacin has been researched along with ro-23-9424 in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (30.00)	18.7374
1990's	7 (70.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertasso, A; Georgopapadakou, NH; Pace, J	1
Beskid, G; Chan, K; Cleeland, R; Keith, DD; McGarry, CM; Siebelist, J	1
Chan, KK; Christenson, JG; Cleeland, R; Dix-Holzknecht, B; Farrish, HH; Patel, IH; Specian, A	1
Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J	1
Gu, JW; Neu, HC	1
Krcméry, V	1
Barry, AL; Jones, RN; Thornsberry, C	1
Bertasso, A; Chan, KK; Chapman, JS; Cleeland, R; Cummings, LM; Dix, BA; Georgopapadakou, NH; Keith, DD	1
Beskid, G; Chan, K; Cleeland, R; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, DH; Unowsky, J	1
Jones, RN; Sanchez, ML	1

Other Studies

10 other study(ies) available for ciprofloxacin and ro-23-9424

Article	Year
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cell Membrane Permeability; Cephalosporins; Ciprofloxacin; Coliphages; DNA Replication; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Porins	1991
In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin. Chemotherapy, 1990, Volume: 36, Issue:2 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Evaluation, Preclinical; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Klebsiella pneumoniae; Meningitis; Mice; Neutropenia; Penicillin Resistance; Pneumonia; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Time Factors	1990
Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:10 Topics: Animals; Anti-Infective Agents; Cefotaxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Dogs; Fleroxacin; Fluoroquinolones; Humans; Injections, Intravenous; Mice; Papio; Rats; Species Specificity	1990
Cephalosporin 3'-quinolone esters with a dual mode of action. Journal of medicinal chemistry, 1990, Volume: 33, Issue:1 Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship	1990
In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests	1990
[Dual cephalosporins--a return of fixed combinations of antibiotics?]. Casopis lekaru ceskych, 1990, Jul-20, Volume: 129, Issue:29 Topics: Anti-Infective Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Fleroxacin; Fluoroquinolones	1990
Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:6 Topics: Anti-Infective Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
Mode of action of the dual-action cephalosporin Ro 23-9424. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7 Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Ciprofloxacin; DNA Replication; DNA, Bacterial; Enterobacter; Escherichia coli; Fleroxacin; Fluoroquinolones; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus	1989
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7 Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pseudomonas	1989
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534. Diagnostic microbiology and infectious disease, 1994, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure	1994